COVID-19 & much more in our latest Industry Update
Articles filtered by tag
Q1’s Industry Insights round up all the latest regulatory news
Our latest Industry Update finishes the year focusing on COVID-19 & BREXIT
Our latest Industry Update for Q2 covers the latest regulatory information around COVID-19 and much more.
Our first Industry Update of 2020 focuses on Clinical Trial Regulation, Brexit and the latest from FDA & EMA.
Nitrosamines, TOPRA, & Drug Development News are the focus for our Q4 Industry Insights
Global Harmonisation of Clinical Trials is the latest focus for our quarterly roundup of the regulatory landscape with news from EMA, FDA and ICH
Our latest Industry Insights focuses on Brexit and news from the regulators around the globe.
Our first Industry Insights of 2019 focuses on the latest regulatory developments and Brexit.
Our latest update from the industry reflects the ongoing uncertainty around BREXIT.